1-[(7-METHOXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-2-AMINO-6-CHLORO-PURINE
Compound with spectra: 1 NMR
![1-[(7-METHOXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-2-AMINO-6-CHLORO-PURINE](/api/compound/CLtOO7aitYT.png?ph=true&h=300&w=458 "1-[(7-METHOXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-2-AMINO-6-CHLORO-PURINE")
| SpectraBase Compound ID | CLtOO7aitYT |
|---|---|
| InChI | InChI=1S/C16H12ClN5O3/c1-24-9-2-3-10-8(4-12(23)25-11(10)5-9)6-22-7-19-13-14(17)20-16(18)21-15(13)22/h2-5,7H,6H2,1H3,(H2,18,20,21) |
| InChIKey | WNHAJZCWMVPLNL-UHFFFAOYSA-N |
| Mol Weight | 357.76 g/mol |
| Molecular Formula | C16H12ClN5O3 |
| Exact Mass | 357.062867 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-[(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-METHYL]-2-AMINO-6-CHLORO-PURINE
2H-1-benzopyran-2-one, 7-methoxy-4-(7-methoxy-2-benzofuranyl)-
(1'R,2'R,3'R,4'R)-2-AMINO-6-CHLORO-9-[3'-ACETOXY-2'-BROMO-4'-(HYDROXYMETHYL)-CYCLOPENTAN-1'-YL]-PURINE
2-Amino-6-chloro-9-(3-deoxy-3-methylene-.beta.,D-erythro-pentofuranosyl)purine
7-[2-(3-fluoro-4-methoxyphenyl)-2-oxo-1-phenylethoxy]-2,3-dihydrocyclopenta[c]chromen-4(1H)-one
methyl 4-{[(8-chloro-4-oxo-1,2,3,4-tetrahydrocyclopenta[c]chromen-7-yl)oxy]methyl}-5-methyl-2-furoate
2-amino-6-chloro-9-beta-D-ribofuranosyl-9H-purine
(1R,2S)-DIBENZYL-3-[4-[(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-METHYL]-1H-1,2,3-TRIAZOL-1-YL]-2-BENZYLOXY-1-HYDROXYPROPYLPHOSPHONATE
(1S,2S)-DIBENZYL-3-[4-[(2-AMINO-6-CHLORO-9H-PURIN-9-YL)-METHYL]-1H-1,2,3-TRIAZOL-1-YL]-2-BENZYLOXY-1-HYDROXYPROPYLPHOSPHONATE
2-(7-HYDROXY-2-OXO-2H-CHROMEN-4-YL)-N-(THYMIDIN-5'-YL)-ACETAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Novel Coumarin Derivatives Containing 1,2,4-Triazole, 4,5-Dicyanoimidazole and Purine Moieties: Synthesis and Evaluation of Their Cytostatic Activity | Molecules | 2012 |